We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 15/15 micrograms/0.3 mL suspension for injection vial (400874)

ARTG ID 400874

ARTG Name

COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 15/15 micrograms/0.3 mL suspension for injection vial

Product name

COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 15/15 micrograms/0.3 mL suspension for injection vial

ARTG Date

23 January 2023

Registration Type

Medicine

Therapeutic good type

Medicine

Ingredients

famtozinameran

tozinameran

Licence category

REP

Licence status

A

Summary

Product information

Consumer medicine information

Related information

COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 15/15 micrograms/0.3 mL suspension for injection vial, Pfizer Australia Pty Ltd, CON-1070

27 February 2023

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 27 February 2023 until 20 January 2025.
COMIRNATY ORIGINAL/OMICRON BA.4-5 (tozinameran/famtozinameran) COVID-19 VACCINE 15/15 micrograms/0.3 mL suspension for injection vial, Pfizer Australia Pty Ltd, CON-1078

27 February 2023

Section 14 consent

Consent to import and supply while noncompliant with standards. The consent is effective from 27 February 2023 until 20 January 2025.